Inventor

SEIFERT ELISABETH

SE11 patents

⚠️ This page may combine multiple inventors who share the name “SEIFERT ELISABETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUNDSTEDT TORBJOERN

3 patents

US8148429B2Apr 3, 2012

Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands

LUNDSTEDT TORBJOERN7 citations81

US8410174B2Apr 2, 2013

Method for treating arthritis

LUNDSTEDT TORBJOERN2 citations60

US8309609B2Nov 13, 2012

Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands

LUNDSTEDT TORBJOERN2 citations60

ACTION PHARMA AS

2 patents

US7442807B2Oct 28, 2008

N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

ACTION PHARMA AS7 citations71

US7186748B2Mar 6, 2007

N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

ACTION PHARMA AS5 citations60

ANAMAR AB

2 patents

US8372878B2Feb 12, 2013

Aminoguanidines as melanocortin receptor ligands

ANAMAR AB4 citations56

US9227927B2Jan 5, 2016

Method of treating inflammation

ANAMAR AB0 citations47

PHARMACIA AB

1 patent

US5658910AAug 19, 1997

Nicotinic acid esters

PHARMACIA AB7 citations69

KABI PHARMACIA AB

1 patent

US5155220AOct 13, 1992

Substituted isoxazolidines and isoxazolines as intermediates for delimopinal

KABI PHARMACIA AB11 citations67

LUNDSTEDT TORBJORN

1 patent

US8227502B2Jul 24, 2012

Amides acting on the adenosine receptors

LUNDSTEDT TORBJORN2 citations51

KABI PHARMACIA AKTIBOLAG

1 patent

US5212305AMay 18, 1993

Process for preparing delmopinol via the intermediates isoxazolidines and isoxazolines

KABI PHARMACIA AKTIBOLAG2 citations50